Kemal Atlay
Benzodiazepines

Prescribing the right pharmacological treatment for generalised anxiety disorder can be tricky.

Take quetiapine, for instance, which is widely prescribed off-label. But despite its effectiveness, the

Kemal Atlay27th February 2019

The sixth known case of HIV transmission in a patient with high adherence to pre-exposure prophylaxis (PrEP) has been reported in the US.

In a detailed case report published in the Lancet HIV, a 21

Sex workers are increasingly facing demands for condomless, penetrative sex compared with a decade ago, researchers say.

And fear of losing clients is contributing to sex workers' “unexpectedly low”

The TGA has given the green light to Australia’s first self-testing kit for HIV, which is expected to increase testing by reducing stigma.

Federal Minister for Health Greg Hunt has today announced

Almost half of patients discharged from hospital after an acute coronary syndrome are missing out on intensive lipid-lowering therapy that could reduce their risk of another event, Australian

Patients with type 2 diabetes on metformin need regular vitamin B12 screening to avoid deficiency and associated peripheral nerve damage, researchers say.

The issue is under-appreciated in clinical

Almost half of patients discharged from hospital after an acute coronary syndrome are missing out on intensive lipid-lowering therapy that could reduce their risk of another event, Australian

Adults on the autism spectrum are more than four times as likely to be taking psychotropic medication than those without the condition, and for many this is inappropriate and a potential risk to their

Being larger than the normal weight range at birth is a better predictor of being overweight or obese in early childhood than a mother’s diabetes status during pregnancy, a Canadian study suggests.

Human rights violations are rare in the Australian health system, but are not unknown.

Last month, a Supreme Court of Victoria judgement ruled on the case of a patient with schizophrenia who was

Children with peanut allergy may eventually be able to rely on a pharmacological safety net against anaphylaxis, following promising results from a trial of an oral immunotherapy, researchers say.